Bausch + Lomb is expanding its ophthalmology portfolio and pipeline, paying Novartis $1.75 billion to acquire a commercialized drug for dry eye disease along with two experimental eye products ...

Bausch + Lomb and Alfa Instruments are also in the process of exploring regulatory requirements and approvals of the surgical dyes in other markets. For more information on VitreoCare, visit www ...

Bausch + Lomb has recalled lenses used during cataract surgery due to complications when the lenses are used, according to an announcement from the Canada-based eyecare company posted on the U.S ...

New Products Will Focus on Dogs' Eyes, Ears and Overall Wellbeing VAUGHAN, ON, Oct. 24, 2022 /PRNewswire/ -- Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb"), a leading global eye ...

However, ex-Bausch + Lomb's contribution, the figure falls to $1.3bn, made up of a $642m contribution from the Salix segment — sales of gastrointestinal products, $291m from the International ...

Bausch + Lomb (NYSE:BLCO) announced that its subsidiaries closed an upsized offering of $790.6 million (€675 million) in ...

The lawsuits, Bausch & Lomb v. PRN Physician Recommended Nutriceuticals, were filed on Sept. 18 in the U.S. District Court for the District of New Jersey. The first suit alleged that two companies ...

Bausch + Lomb announced on Monday the debut of its Project Watson line of eye, ear and overall wellness products for dogs. The Project Watson product line is set to include eye and ear washes, eyelid ...

Bausch & Lomb has manufactured eye health products and vision care solutions since 1853. The company is a global supplier of contact lenses, lens care products and ophthalmic pharmaceuticals. Pros.

Eye products giant Bausch & Lomb Corp. on Wednesday announced the immediate departure of general counsel Christina Ackermann and said she will be replaced Bob Bailey, who spent 18 years at the ...

View Bausch + Lomb Corporation BLCO stock quote prices, financial information, real-time forecasts, and company news from CNN.